Table 3

Cox regression analysis: the effect of CPAP on fatal and non-fatal MACEs (n=1860)

No OSAMild OSAUntreated
moderate–severe OSA
Treated
moderate–severe OSA
Incident MACEs
 No. of subjects316436843265
 Incident MACEs, n (%)31 (9.8%)63 (14.4%)146 (17.3%)38 (14.3%)
 Unadjusted HRRef1.48 (0.97 to 2.28)1.90 (1.29 to 2.80)1.52 (0.95 to 2.45)
 Partially adjusted HR*Ref1.10 (0.71 to 1.69)1.06 (0.70 to 1.60)0.88 (0.53 to 1.45)
 Fully adjusted HR†Ref1.10 (0.71 to 1.70)1.02 (0.67 to 1.55)0.93 (0.56 to 1.56)
Incident non-fatal MACEs
 No. of subjects316436843265
 Incident MACEs, n (%)29 (9.2%)60 (13.8%)138 (16.4%)38 (14.3%)
 Unadjusted HRRef1.51 (0.97 to 2.35)1.92 (1.28 to 2.86)1.63 (1.01 to 2.64)
 Partially adjusted HR*Ref1.13 (0.72 to 1.76)1.09 (0.71 to 1.67)0.96 (0.58 to 1.60)
 Fully adjusted HR†Ref1.13 (0.72 to 1.77)1.05 (0.68 to 1.63)1.03 (0.61 to 1.75)
  • *Partially adjusted for age, gender, body mass index.

  • †Fully adjusted for age, gender, body mass index, waist circumference, body weight change, Epworth sleepiness scale, total sleep time, cigarette smoking, alcohol use, physical activity, prior hypertension, prior cardiovascular disease, prior hyperlipidaemia and prior diabetes.

  • CPAP, continuous positive airway pressure; HR, hazard ratio; MACEs, major adverse cardiovascular events; OSA, obstructive sleep apnoea.